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Abstract
Acid dependent infection of Hela and Vero cells by BTV-10 occurs from within early-endosomes following virus uptake by
clathrin-mediated endocytosis (Forzan et al., 2007: J Virol 81: 4819–4827). Here we report that BTV-1 infection of BHK cells is
also dependent on a low endosomal pH; however, virus entry and infection were not inhibited by dominant-negative
mutants of Eps15, AP180 or the ‘aa’ splice variant of dynamin-2, which were shown to inhibit clathrin-mediated endocytosis.
In addition, infection was not inhibited by depletion of cellular cholesterol, which suggests that virus entry is not mediated
by a lipid-raft dependent process such as caveolae-mediated endocytosis. Although virus entry and infection were not
inhibited by the dominant-negative dynamin-2 mutant, entry was inhibited by the general dynamin inhibitor, dynasore,
indicating that virus entry is dynamin dependent. During entry, BTV-1 co-localised with LAMP-1 but not with transferrin,
suggesting that virus is delivered to late-endosomal compartments without first passing through early-endosomes. BTV-1
entry and infection were inhibited by EIPA and cytochalasin-D, known macropinocytosis inhibitors, and during entry virus
co-localised with dextran, a known marker for macropinocytosis/fluid-phase uptake. Our results extend earlier observations
with BTV-10, and show that BTV-1 can infect BHK cells via an entry mechanism that is clathrin and cholesterol-independent,
but requires dynamin, and shares certain characteristics in common with macropinocytosis.
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Introduction
Virus internalisation is initiated by binding to specific receptors
at the cell-surface and culminates in host-cell membrane
penetration and delivery of the viral genome to the site of
replication. For many viruses, membrane penetration follows virus
endocytosis. Several different endocytosis pathways operate in
mammalian cells which deliver cargoes to distinct intracellular
locations [1,2]. Clathrin-mediated endocytosis (CME) is the major
pathway for receptor-dependent endocytosis in many cell types
and is dependent on adaptor proteins, such as the AP-2 complex,
the GTPase dynamin [2,3], and several other important accessory
molecules including AP180 and Eps-15 [4,5,6]. CME delivers
cargoes to acidic endosomes; initially to early-endosomes where
they are sorted for transport to either late-endosomes/lysosomes
for degradation or to recycling-endosomes for recycling back to
the cell surface. Several acid-activated viruses are known to exploit
the low pH within vesicles derived from the clathrin pathway, to
trigger capsid un-coating and/or membrane penetration [7].
Clathrin-independent endocytosis includes the caveolae path-
way which is dependent on caveolin, lipid-rafts and cholesterol
[1,2]. Cargoes internalised by caveolae are delivered to neutral pH
caveosomes [8,9]. From caveosomes, cargoes can traffic to the ER
or Golgi [10,11,12]. Like CME, caveolae-mediated uptake
requires dynamin and can be inhibited by expression of
dominant-negative (DN) mutants of dynamin-2 [10,12]. A number
of viruses use caveolae for infection [10,13,14,15,16] and much of
our knowledge of caveolae comes from studies with simian virus-
40 [10,17,18]. A number of caveolin-independent pathways also
originate from lipid-rafts, and novel clathrin- and raft-independent
processes have also been identified. These pathways have different
requirements for cellular proteins such as dynamin, flotillin, small
GTPases, and for cholesterol and other specific lipids
[1,2,19,20,21,22,23,24,25], and can also be exploited by viruses
for infection [21,26,27,28,29,30,31].
Macropinocytosis is the major form of endocytosis responsible
for the majority of fluid-phase uptake for a number of cell types
[32]. Macropinocytosis is characterised by actin-dependent
reorganisations of the plasma membrane to form macropino-
somes, morphologically heterogenic vesicles that lack coat
structures. Macropinocytosis is constitutive in many cell types
but in others requires activation by growth factors [32,33,34] and
contributes significantly to antigen presentation by specialised
antigen presenting cells [32,34,35]. Macropinocytosis is also
exploited by a wide range of important animal pathogens for cell
invasion and possibly the avoidance of immune surveillance [36].
Here we have investigated the entry route used by bluetongue
virus serotype 1 (BTV-1) to infect BHK cells. Bluetongue virus (BTV)
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Reoviridae which includes many important pathogens for man and
animals [37]. BTV exists as at least 25 serotypes [38,39] and is the
etiological agent of bluetongue, a severe and economically
important haemorrhagic disease of ruminants. Bluetongue is
arthropod-borne and primarily transmitted between susceptible
animal hosts by certain species of Culicoides biting midges [40].
BTV is non-enveloped and consists of a 3 layered protein capsid
(outer-capsid, core and sub-core) surrounding a genome of ten linear
segments of double-stranded RNA. The outer capsid is formed from
two viral proteins, VP2 and VP5, while the inner core-particle
consists of a ‘core-surface’ layer composed of VP7, which surrounds
a sub-core shell composed of VP3. VP2 interacts with host cell-
surface receptors serving as a virus-attachment protein while VP5 is
involved in host-cell membrane penetration [41,42,43]. The outer
capsid proteins are removed during cell entry, and transcriptionally
active core particles are released into the cytosol where virus
replication occurs [44,45]. However, the core-particle is also
infectious in its own right demonstrating that VP7 can also mediate
cell attachment and membrane penetration, possibly by a distinct
mechanism [46]. Other viral encoded proteins (NS1, NS2 and NS3)
are also produced in infected cells where they are involved in virus
replication and release of progeny virus particles [47].
Infection by BTV is acid-activated and requires the low pH
within endosomes for disassembly of the outer viral capsid and
membrane penetration, and BTV particles have been described
inside endosomes which have the appearance of clathrin-coated
vesicles [48]. Recent studies have concluded that entry and
infection of Vero and Hela cells by BTV-10 occurs via CME, with
capsid disassembly and membrane penetration within early-
endosomes [45]. Here we describe the use of pharmacological
and DN inhibitors of endocytosis to investigate entry and infection
of BHK cells by BTV-1. We found that the clathrin pathway is not
the major entry route used by BTV-1 to infect BHK cells. Instead
we found that the entry mechanism shares certain characteristics
in common with macropinocytosis and appears to deliver virus
directly to late endosomal compartments. These studies extend
earlier observations and show that BTV joins an increasing
number of viruses that can exploit multiple endocytosis pathways
for infectious entry.
Methods
Cells and viruses
Baby Hamster Kidney (BHK)-21 cells (clone 13) were obtained
from the European Cell Culture Collection and maintained at
37uC, 5% CO2, in Glasgow Minimum Essential Medium
(GMEM) (Sigma) containing 10% foetal bovine serum (FBS)
(Autogen Bioclear), 2 mM glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin and 5% tryptose phosphate broth
solution (Sigma).
The South African reference strain of BTV-1 (IAH reference
number RSArrrr/01, ICTVdb isolate accession number
41010B4F) was grown on BHK cells and gradient purified
according to previously published methods [49]. Purified virus
was stored at 4uC in the presence of sodium-N-lauroylsarcosine
(0.1%) to prevent virus aggregation and was used for all
experiments [46,49]. Viruses were diluted immediately before
use thereby reducing the concentration of sodium-N-lauroylsarco-
sine to ,0.01% which showed no cytotoxic effects.
Antibodies and reagents
Rabbit anti-BTV/NS2 (Orab 1) and the Guinea-pig anti-BTV/
VP5 (PM10) antibodies were produced at the Institute for Animal
Health using recombinant NS2 and BTV-1 as immunogens
respectively. The specificity of these antibodies was verified by
western blotting against purified BTV-1 and a BTV-1 infected
BHK cell lysate using uninfected cells as a negative control, and by
showing a lack of cross-reactivity with uninfected BHK cells by
confocal microscopy. Mab 9E10 (anti-c-myc) was from the
Developmental Studies Hybridoma Bank (University of Iowa).
The mouse monoclonal antibody (Mab 4A1) to Lysosomal
Antigen -1 (LAMP-1) was from Jean Gruenberg (University of
Geneva). Species specific, Alexa-Fluor conjugated secondary
antibodies were from Invitrogen.
Methyl-b-cyclodextrin, filipin, cytochalasin-D, dynasore mono-
hydrate, and 5-(N-Ethyl-N-isopropyl)-amiloride (EIPA) were from
Sigma. Ammonium chloride and concanamycin-A were from
Fluka. Latrunculin-A, and Alexa-Fluor labelled human transferrin,
dextran and phalloidin were from Invitrogen. Stock solutions of
Methyl-b-cyclodextrin, transferrin and dextran were made in
GMEM, and ammonium chloride in sterile water. Stock solutions
of phalloidin were made in methanol. Stock solutions of other
inhibitors were made in dimethyl sulfoxide (DMSO). Where
appropriate, an equivalent dilution of DMSO (or methanol) was
included in the mock treatment.
Plasmids and cell transfection
The plasmid for expression of c-myc tagged AP180C was from
Harvey McMahon (MRC. Cambridge. UK). Plasmids for
expression of green fluorescent protein (GFP)-tagged wt and
dominant-negative (DN)-dynamin-2 (K44A) were from Mark
McNiven (Mayo Clinic. Rochester. USA). Plasmids for GFP-
DN-Eps15 and control GFP-Eps15 were from Alexandre
Benmerah (Universite ´ Paris Descartes. Paris. France).
Cells were seeded on glass coverslips (BDH) in antibiotic-free
cell-culture medium and transfected when ,60% confluent. Cells
were transfected in Optimem (Invitrogen) using a ratio of 1 mg
plasmid DNA to 1 ml Lipofectamine 2000 (Invitrogen) according
to the manufacturers guidelines. Cells were incubated at 37uC, 5%
CO2 for 4 h when the transfection medium was replaced with
antibiotic-free cell-culture medium. Cells were used for experi-
ments at 12 h post-transfection. Cells expressing a transgene were
identified by confocal microscopy. Transfection efficiencies
(determined by GFP or c-myc expression) ranged from 30–43%.
Virus entry, infection and inhibitor assays
For entry experiments with transfected cells, BTV-1 (13 mg/ml
in GMEM) was bound to the cells at 4uC for 40 minutes.
Unbound virus was removed by washing and the cells placed at
37uC (in GMEM) to initiate entry. Where specified, inhibitors
were added to the cells for 0.5 h before the virus binding step and
remained present throughout the assay. All entry experiments
were ended at the times indicated by the addition of 4%
paraformaldehyde (PFM), with the exception of those involving
transferrin which were ended using 4% PFM with 0.25%
glutaraldehyde. Input virus was detected using the anti-VP5
antibody, PM10. For quantification of virus uptake, cells with
cytoplasmic labelling for BTV were scored as positive. In all
experiments, ,94% of the control cells showed virus uptake.
For infections with transfected cells, the cells were inoculated
with BTV-1 at a multiplicity of infection (m.o.i.) of 1 infectious
virus particle per cell, in serum-free medium for 1 h at 37uC.
Unbound virus was removed by washing with GMEM and the
cells returned to 37uC in cell culture medium with reduced (2%)
FBS.
Inhibitors (Methyl-b-cyclodextrin, cytochalasin-D or latruncu-
lin-A) were added to cells for 0.5 h before infection. The cells were
Bluetongue Virus Cell-Entry
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presence of an inhibitor. Mock-treated cells were infected in the
absence of an inhibitor. After the 1 h incubation with virus, the
cells were washed with GMEM to remove unbound virus and
returned to 37uC in cell culture medium with reduced (2%) FBS,
and supplemented further with 25 mM ammonium chloride. To
control for any effects on intracellular virus replication the
inhibitors were also added to other cells immediately after the
virus inoculums were removed and coincident with the addition of
ammonium chloride.
In the experiment shown in figure 2, BTV-1 (m.o.i.=1) was
bound to the cells at 4uC for 40 minutes. The cells were then
washed to remove unbound virus and placed at 37uC (in GMEM)
to initiate infection. This allowed the addition of inhibitor to be
synchronized with the start of infection. Concanamycin-A was
added to the cells at the noted times. When used as a pre-
treatment, concanamycin-A was added for 0.5 h at 37uC before
the addition of virus and remained present only during the virus
binding step. Concanamycin-A was also added to other cells,
either coincident with the start of infection (i.e. on shifting the cells
to 37uC) or at various times after infection was initiated.
All infection experiments were ended after 12 h by the addition
of cold 4% PFM for 40 minutes. Infected cells were identified
using confocal microscopy and the anti-NS2 antibody, Orab1. For
quantification of infection, cells with cytoplasmic labelling for BTV
NS2 were scored as positive.
Endocytosis of Alexa-Fluor labelled ligands
The ability of cells to internalize through the clathrin pathway
was determined by observing transferrin uptake by confocal
microscopy. Cells were serum starved for 0.5 h prior to the
addition of Alexa-568 labelled transferrin (25 mg/ml) in GMEM at
37uC for the times indicated in the results. For quantification of
transferrin uptake, cells with cytoplasmic labelling for Alexa-568
transferrin were scored as positive. Alexa-568 labelled dextran
(5 mg/ml) was added to the cells as described for transferrin. In all
experiments, .98% of the control cells showed transferrin or
dextran uptake.
Immunofluorescence confocal microscopy
After cell fixation with PFM, the cells were washed with PBS
pH 7.5 (Sigma) and permeablized with 0.1% Triton X-100
(Sigma) in Phosphate Buffered Saline (PBS) for 20 minutes. When
using Mab 4A1 to identify LAMP-1 positive compartments, the
cells were permeablized with 0.5% Saponin (in place of Triton X-
100) for 15 minutes and 0.1% Saponin was included in all
subsequent steps. Non-specific binding sites were blocked with
block buffer (100 ml Tris-buffered saline supplemented with
1 mM CaCl2, 0.5 mM MgCl2, 10% Normal Goat Serum (Harlan
Lab Sera) and 1% Teleostean Gelatin [Sigma]) for 0.5 h. The cells
were washed with PBS and incubated with primary antibodies in
block buffer for 1 h, washed again with PBS, and incubated with
the appropriate species specific, Alexa-Fluor conjugated secondary
antibody (also in block buffer) for 1 h. The cells were washed and
the nuclei labelled with 49,6 9-Diamidino-2-Phenylindole (DAPI)
(Sigma) in H2O for 10 minutes and then washed with H2O. The
coverslips were mounted in Vectashield mounting medium for
fluorescence (Vector Laboratories) and sealed with clear nail
varnish.
Transfected cells expressing dynamin or Eps15 constructs were
identified by the GFP fusion tag. Transfected cells expressing
AP180C were identified using the anti-c-myc antibody (9E10) and a
goat, anti-mouse Alexa-488 conjugated secondary antibody.
LAMP-1 positive compartments were labelled using Mab 4A1.
All data were collected sequentially to eliminate cross talk between
fluorescent dyes on a Leica SP2 Confocal Scanning Laser
Microscope. For experiments that involved dual labelling of virus
and cellular compartments, the specificity of the secondary
antibodies for the target primary antibody was confirmed by
showing a lack of cross-reactivity with non-target primary
antibodies. The data are shown as single optical sections through
the middle of the cell.
Labelling of cellular cholesterol and actin filaments
Cellular cholesterol was visualised at 430 nm immediately after
labelling with 125 mg/ml filipin diluted in PBS for 15 minutes at
room temperature [50]. To label for actin filaments, cells were
fixed and permeabilized (as above) and incubated with Alexa-488
labelled phalloidin diluted in block buffer for 10 minutes at room
temperature.
Data analysis
For experiments with DN-dynamin-2 or DN-Eps15, uptake of
transferrin and virus was normalised to the results obtained for
cells expressing the control (wt dynamin-2 or the Eps15 control
respectively). Over-expression of wt AP180 inhibits CME and
cannot be used as a control for AP180C [6]. Therefore, for
experiments with AP180C, transferrin or virus uptake was
normalised to the results obtained for cells of the non-expressing
population (i.e. the non-green cells). Similarly, for DN-dynamin-2
or AP180C, infection was normalised to the level of infection of
cells expressing wt dynamin-2 or cells of the non-expressing
population, respectively. The level of infection of inhibitor-treated
cells was normalised to the levels of infection of the mock-treated
controls. Student’s t test was used to determine statistical
significance.
Results
Infection of BHK cells by BTV-1 is clathrin- and
cholesterol-independent, but requires active endosomal
acidification
It has been reported that BTV-10 infects Hela and Vero cells
using CME for entry [45]. Here we have investigated the
involvement of the clathrin pathway in BTV-1 entry and infection
of BHK cells using deletion mutants of AP180 (AP180C) and
Eps15 (Eps15-Ed95/295; from here known as DN-Esp15) which
act as DN inhibitors of CME and block uptake of transferrin
[5,6,51]. BHK cells were transiently transfected to express
AP180C-c-myc, GFP-DN-Eps15, or a control GFP-Eps15
(D3D2; from here known as ‘Esp15 control’) that does not
interfere with the clathrin pathway [5,51]. At 12 h post-
transfection, the cells were incubated with Alexa-568 labelled
transferrin for 15 minutes or with BTV-1 for 0.5 h. The cells were
then fixed and processed for confocal microscopy (Fig. 1). Virus
was detected using PM10 (anti-VP5) and an Alexa-568 conjugated
secondary antibody. Cells expressing Eps15 proteins or AP180C
were identified by the GFP or c-myc fusion tags respectively (see
methods) and are shown in green on figure 1. Cells were scored for
transferrin or BTV uptake as described in the methods. For each
DN protein, uptake of transferrin or BTV was normalised to the
results obtained for the controls (see methods). In cells expressing
GFP-DN-Eps15 the frequency of transferrin uptake was reduced
by 53% when compared to cells expressing the Eps15 control
(Fig. 1A, B, E, F and O) indicating a block to clathrin-mediated
endocytosis. Similarly, the frequency of transferrin uptake was
reduced by 82% in cells expressing AP180C when compared to
cells of the non-expressing population (Fig. 1I, J and O). In
Bluetongue Virus Cell-Entry
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GFP-Eps15 control (A–D), GFP-DN-Eps15 (E–H) or AP180C-c-myc (I–N). Cells expressing a transgene are shown in green. The transfected cells were
incubated with Alexa-568 transferrin or with BTV-1 (shown as red; see Methods). Panels (A), (E) and (I) show transferrin uptake, whereas panels (B), (F)
and (J) show merged images for transferrin and transgene expression for the same cells as in panels A, E and I. Panels (C), (G) and (K) show uptake of
BTV-1, whereas panels (D), (H) and (L) show merged images for virus labelling and transgene expression for the same cells as in panels C, G and K.
Bluetongue Virus Cell-Entry
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AP180C (Fig. 1K, L and O) did not significantly inhibit virus
uptake. In virtually all cells expressing the DN proteins the pattern
of virus labelling was indistinguishable from cells expressing the
Esp15 control or cells that were not expressing a transgene. These
results show that under conditions where clathrin-mediated uptake
of transferrin is inhibited BTV-1 is taken up normally by BHK
cells.
The above experiments required using a relatively high BTV-1
concentration (13 mg/ml), to allow virus detection during entry.
This raises the possibility that the virus may have been forced to
enter the cells via an endocytic pathway that is not normally used,
Alternatively, AP180C transfected cells were infected with BTV-1 (m.o.i.=1). At the end of the infection the cells were processed for confocal
microscopy using Orab1 (anti-NS2) to identify infected cells (shown in red on Panels M and N). Panel (M) shows infected cells whereas panel (N) show
a merged image for infection and AP180C expression for the same cells as in panel M. The cell nuclei are shown in blue. Scale bar =10 mm. Panel (O):
Cells were scored positive for transferrin or BTV-1 uptake, or for infection as described in the methods. For AP180C, both the expressing and the non-
expressing cell populations were or scored for transferrin uptake (total cells counted for each population .900; n=6 experiments), for BTV uptake
(.500 cells; n=4) and for infection (.300; n=3). The level of transferrin or BTV-1 uptake, or infection by the cells expressing AP180C (EC) was
normalised to the level of uptake or infection by the cells of the non-expressing population (NEC). For Eps15 experiments, cells were scored for
transferrin (.280 cells; n=4) or BTV-1 uptake (.280 cells; n=4) and level of uptake by the cells expressing DN-Eps15 (DN) was normalised to the
results for the cells expressing the Esp15 control. The mean 6 SD is shown for the independent experiments (P values: *** ,0.001).
doi:10.1371/journal.pone.0011360.g001
Figure 2. Active endosomal acidification is required for BTV infection. BHK cells were mock-treated or pre-treated (PT) with 12 nM
concanamycin-A, and then infected with BTV-1 (m.o.i.=1). Alternatively, concanamycin-A was added to the cells coincident with the start of infection
(Time 0 on panel C) or at the noted times after infection was initiated. At the end of the infection the cells were processed for confocal microscopy
counting at least 700 cells per time point. Infected cells were identified using Orab1 (anti-NS2) and are shown in red. Panel (A) shows mock treated
cells infected with BTV-1. Panel (B) shows infected cells that had been pre-treated with drug. The cell nuclei are shown in blue. Scale bar =10 mm.
Panel (C): The level of infection of the drug treated cells was normalised to the levels of infection of the mock treated cells. The mean of duplicate
samples for one experiment of two is shown, each giving similar results.
doi:10.1371/journal.pone.0011360.g002
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the effect of AP180C expression on BTV-1 infection at a low
m.o.i., to encourage virus uptake by the most efficient route. At
12 h post-transfection, the cells were incubated with BTV-1
(m.o.i.=1) for 1 h at 37uC. The cells were then washed to remove
excess virus and infection continued for a further 11 h when the
cells were fixed and processed for confocal microscopy. Cells
expressing AP180C were identified using expression of the c-myc
tag as described above. Infected cells were identified using a rabbit
antibody (Orab1) that binds the viral NS2 protein (a marker of
virus replication) and an Alexa-568 conjugated secondary
antibody. Intense areas of NS2 labelling were detected within
infected cells (Fig. 1M and N). Cells expressing AP180C were
scored for infection (indicated by labelling for NS2) and the results
normalised to the results obtained for the non-expressing cell
population. In the cells expressing AP180C the frequency of
infection was similar to that of the non-expressing cell population,
indicating that AP180C does not inhibit infection (Fig. 1O). These
results show that virus uptake by cells expressing AP180C leads to
infection and support the conclusion that CME is not the major
pathway used by BTV-1 for entry into BHK cells.
BTV infection is known to be dependent on the low pH within
endosomes [45]. Concanamycin-A is a potent and specific
inhibitor of the vacuolar proton ATPase and is commonly used
to raise endosomal pH [52]. Pre-treatment of BHK cells with
concanamycin-A inhibited BTV-1 infection (Fig. 2A and 2B)
confirming the requirement for active endosomal acidification.
Similarly, when concanamycin-A was added coincident with the
start of infection (i.e. at time 0 on figure 2C) a strong inhibitory
effect was also seen. When added after the start of infection,
concanamycin-A also had an inhibitory effect on infection. When
added 2 h after infection was initiated, the frequency of infection
was reduced by ,50% when compared to mock treated cells
(Fig. 2C). Near identical results were obtained using ammonium
chloride in place of concanamycin-A (data not shown). These
results suggest that BTV-1 is delivered to acidic endosomes much
slower than expected for uptake by CME [53].
Raising endosomal pH may prevent receptor recycling, which
could deplete the cell surfaces of attachment receptors and thereby
reduce infection. However, the pattern of virus uptake by
concanamycin-A treated cells (detected at 0.5 h post-uptake by
confocal microscopy using the PM10 antibody) was indistinguish-
able from mock-treated cells (data not shown), indicating that the
inhibitory effect of concanamycin-A on infection was not due to a
failure of the virus to be internalised.
It has recently been shown that cargo internalised via caveolae
can be delivered to acidic early-endosomes [17]. Caveolae-
mediated endocytosis is dependent on the integrity of lipid-rafts,
and like other raft mediated endocytic pathways can be inhibited
by cholesterol depletion [8,20]. The effect of cholesterol depletion
on BTV-1 infection was investigated using methyl-b-cyclodextrin
(MbCD) which binds and extracts cholesterol from the plasma
membrane. BHK cells were mock-treated or treated with MbCD
for 0.5 h at 37uC. The cells were then incubated with filipin which
binds cholesterol and can be detected by fluorescence microscopy.
Filipin fluorescence was detected at the plasma membrane and
within the cytosol of mock-treated cells (Fig. 3A). In contrast,
although fluorescence was detected within the cytosol, the intense
plasma membrane fluorescence generated by filipin binding was
greatly reduced by MbCD, indicating extensive and selective
cholesterol depletion from the cell surfaces (Fig. 3B).
MbCD treated cells were also infected with BTV-1 (m.o.i.=1)
for 1 h in the presence of the drug (see methods). Mock-treated
cells were infected in parallel. After washing the cells to remove
excess virus and drug, infection was continued for a further 11 h.
At the end of infection, the cells were processed for confocal
microscopy using NS2 to detect infected cells. Figure 3C shows
that pre-treatment of cells with MbCD did not inhibit infection
when compared to mock-treated cells. These results show that the
cell entry mechanism used by BTV-1 to infect BHK cells does not
require cholesterol and is, therefore unlikely to be mediated by
caveolae or other lipid-raft mediated endocytic pathways.
Entry of BTV-1 into BHK cells is dynamin dependent
The involvement of dynamin in BTV-1 entry and infection was
investigated using a DN mutant of the ‘aa’ splice variant of
dynamin-2 [3,54,55]. BHK cells were transiently transfected to
express GFP-wt ‘aa’ dynamin-2, or GFP-DN ‘aa’ dynamin-2. At
12 h post-transfection, the cells were incubated with Alexa-568
labelled transferrin for 15 minutes or with BTV-1 for 0.5 h. The
Figure 3. Selective cholesterol depletion from the plasma membrane does not inhibit BTV-1 infection. BHK cells were mock-treated (A)
or pre-treated with 7.5 mM MbCD (B) and then incubated with filipin and viewed by confocal microscopy (see Methods). Blue fluorescence represents
filipin binding to cholesterol. Scale bar =10 mm. Panel (C): MbCD and mock-treated cells were infected with BTV-1 (m.o.i.=1). At the end of
the infection the cells were labelled using Orab1 (anti-NS2) and scored for infection by confocal microscopy counting at least 500 cells for both the
mock-and drug-treated cells. The level of infection of the drug-treated cells was normalised to the level of infection of the mock-treated cells. The
mean 6 SD for triplicate samples of one experiment representative of two is shown, each giving similar results.
doi:10.1371/journal.pone.0011360.g003
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(Fig. 4). Virus was detected using PM10 (anti-VP5) and an Alexa-
568 conjugated secondary antibody. Cells expressing wt or DN-
dynamin-2 were identified by the GFP fusion tag and are shown in
green. The cells expressing GFP-DN-dynamin-2 showed transfer-
rin uptake at a lower frequency than cells expressing the wt
construct (Fig. 4A-D and 4I) indicating a block to clathrin-
mediated endocytosis. In contrast, BTV-1 was taken up normally
by cells expressing DN-dynamin-2 (Fig. 4E–H and 4I).
At 12 h post-transfection, cells were also infected with BTV-1
(m.o.i.=1) for 1 h at 37uC. The cells were then washed to remove
excess virus and infection continued for a further 11 h when the
cells were fixed and processed for confocal microscopy. Infected
cells were identified using a rabbit antibody (Orab1) as described
above. The frequency of infection of the cells expressing DN-
dynamin-2 was normalised to the level of infection of the cells
expressing the wt protein. Figure 4I shows that expression of DN-
dynamin-2 does not inhibit BTV-1 infection. These results are
consistent with those obtained using DN-Esp15 and AP180C and
support our conclusion that BTV-1 can enter BHK cells using a
clathrin-independent pathway. Furthermore, as the ‘aa’ splice
variant of DN-dynamin-2 also inhibits caveolae-mediated endo-
cytosis, the above results also support our conclusion that caveolae
are unlikely to be required for virus entry and infection.
To further investigate the role of dynamin in BTV-1 infection,
BHK cells were treated with the general dynamin inhibitor,
dynasore [56]. Mock-treated and dynasore-treated cells were
incubated with BTV-1, Alexa-568 labelled transferrin or Alexa-
568 labelled dextran. Figure 5A-F shows representative cells and
that dynasore effectively inhibited uptake of all three ligands.
Virtually all of the drug treated cells (n.300 cells per ligand)
showed no uptake of virus, transferrin or dextran.
We also investigated the effects of dynasore on BTV-1 infection.
However, these experiments were inconclusive as ,6 h after the
drug was removed, the cells detached from the coverslips
indicating a delayed cytotoxic effect. Nevertheless, the observation
that dynasore inhibits entry of BTV-1 into BHK cells shows that
the entry mechanism is dynamin dependent.
BTV-1 entry into BHK cells shares characteristics with
macropinocytosis
A number of endocytic processes are dependent on functional
actin dynamics [2]. Therefore we determined if BTV-1 entry into
BHK cells requires actin using cytochalasin-D which disrupts actin
filaments. Cells were mock-treated, or treated with the drug and
successful disruption of actin filaments confirmed by confocal
microscopy after labelling the cells with Alexa-488 labelled
phalloidin (data not shown). Mock or drug-treated cells were
allowed to internalise BTV-1 (for 0.5 h) in the presence of the
Figure 4. DN-dynamin-2 does not inhibit BTV-1 infection. BHK
cells were transfected to express wt dynamin-2 (Panels A, B, E and F) or
DN-dynamin-2 (panels C, D, G and H). Cells expressing the transgene are
shown in green. The transfected cells were incubated with Alexa-568
transferrin or with BTV-1 (shown as red). Panels (A) and (C) show
transferrin uptake, whereas panels (B) and (D) show merged images for
transferrin and transgene expression for the same cells as in panels A
and C. Panels (E) and (G) show uptake of BTV-1, whereas panels (F) and
(H) show merged images for virus and transgene expression for the
same cells as in panels E and G. The cell nuclei are shown in blue. Scale
bar =10 mm. Alternatively, transfected cells were infected with BTV-1
(m.o.i.=1). At the end of the infection the cells were labelled using
Orab1 (anti-NS2) and scored for infection by confocal microscopy. Panel
(I): Cells were scored positive for transferrin or BTV-1 uptake, or for
infection as described in the methods counting at least 220 cells (n=3
experiments) for each condition. The level of transferrin or BTV-1
uptake, or infection by the cells expressing DN-dynamin-2 (DN) was
normalised to the level of uptake or infection by the cells expressing wt
dynamin-2 (wt). The mean 6 SD is shown for three independent
experiments (P values: *** ,0.001).
doi:10.1371/journal.pone.0011360.g004
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microscopy using PM10 to detect input virus as described above.
Figure 6A and 6B show representative cells and that cytochalasin-
D effectively blocked entry of BTV. Virtually all of the drug-
treated cells (n.200 cells) showed a pattern of virus labelling as
shown on the figure. In contrast, figure 6C and 6D show that
cytochalasin-D did not inhibit uptake of 568-Aexa labelled
transferrin, or 568-Alexa labelled dextran. These results show
that BTV-1 uptake by BHK cells is actin-dependent and confirms
that BTV-1 and transferrin enter cells via different mechanisms.
Cytochalasin-D treated cells were also infected with BTV-1 for
1 h in the presence of the drug (see methods). Mock-treated cells
were infected in parallel. After the 1 h incubation with virus the
cells were washed to remove excess unbound virus and inhibitor,
and infection continued for a further 11 h. At the end of infection
the cells were processed for confocal microscopy using NS2 to
detect infected cells. The effects of cytochalasin-D on actin
filaments are reversible and it is possible that following drug wash-
out, virus that remained bound to the outsides of the cells (as a
result of actin disruption) may cause an infection. Therefore
Figure 5. EIPA and dynasore inhibit BTV-1 endocytosis. BHK cells were mock-treated (A–C) or pre-treated with 100 mM dynasore (D–F), or
100 mM EIPA (G–I) and allowed to internalise BTV-1 (Panels A, D and G) or Alexa-568 labelled dextran (Panels C, F and I) for 0.5 h, or Alexa-568 labelled
transferrin (Panels B, E and H) for 15 minutes, and processed for confocal microscopy using PM10 to detect input virus (shown as green). The cell
nuclei are shown in blue. Note: EIPA treatment results in a faint blue fluorescence throughout the cytosol. Scale bar =10 mm.
doi:10.1371/journal.pone.0011360.g005
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ately after the virus inoculums and cytochalasin-D was removed.
Ammonium chloride is a membrane permeable weak base that
rapidly raises endosomal pH [57] and was added to prevent
further infection events by virus that have not yet entered the cell
and undergone acid-induced membrane penetration. Under these
conditions infection can only occur during the period when
cytochalasin-D was present. To control for possible effects on
intracellular virus replication, cytochalasin-D was also added to
other cells immediately after the virus inoculums were removed
and co-incident with the addition of ammonium chloride. Under
these conditions, cytochalasin-D can only have an inhibitory effect
on infection by interfering with post-entry virus replication.
Figure 6E shows that pre-treatment of BHK cells with cytocha-
lasin-D inhibited BTV-1 infection. In contrast, when added after
the virus internalisation step no inhibitory effect was seen (Fig. 6E).
Similar results were obtained using latrunculin-A in place of
cytochalasin-D (Fig. 6E). These results confirm that BTV-1
infectious entry into BHK cells is actin dependent.
Macropinocytosis is actin dependent and is increasingly
recognised as an important cell entry route for a number of
viruses [36]. Macropinocytosis is also dependent on the amiloride-
sensitive Na
+/H
+ exchangers [36] and is inhibited by 5-(N-ethyl-
N-isopropyl)-amiloride (EIPA). EIPA has previously been shown to
inhibit macropinocytosis without affecting other endocytic path-
ways such as CME [58]. Figure 5 shows representative cells and
that EIPA effectively inhibited uptake of dextran (Fig. 5I) and
BTV-1 (Fig. 5G). Virtually all of the drug treated cells showed no
uptake of dextran or virus (n.300 cells counted for each ligand).
In contrast, EIPA did not inhibit uptake of transferrin (Fig. 5H) as
virtually all cells showed transferrin uptake; (n.300 cells counted).
These results also suggest that BTV-1 entry may be mediated by
macropinocytosis or a macropinocytosis-like mechanism. In
addition, as EIPA blocked uptake of BTV-1 but not transferrin,
these observations strengthen our conclusion that BTV-1 entry is
not mediated by the clathrin pathway.
Although commonly used as a marker to indicate uptake by
macropinocytosis, dextran is likely to enter cells by other pathways
that participate in fluid-phase uptake. Certainly, our results with
cytochalasin-D show that dextran can enter BHK cells using an
actin-independent pathway, as although actin filaments were
disrupted by cytochalasin-D, dextran uptake appeared to be
unaffected (see Fig. 6D). Nevertheless, figure 7 shows that at 0.5 h
and 2 h post uptake, BTV-1 was co-localised with co-internalised
Alexa-568 labelled dextran, which also suggest that BTV-1 may
use macropinocytosis or a macropinocytosis-like mechanism to
enter BHK cells.
BTV-1 is delivered to Lamp-1 positive endosomes during
entry
The results described above show that BTV-1 infection of BHK
cells occurs via a clathrin-independent entry mechanism that
shares certain characteristics with macropinocytosis. Macropino-
somes can fuse with lysosomes or recycle their contents back to the
extracellular space, most likely via early- and recycling-endosomes
[32,59,60]. Therefore, we investigated whether BTV-1 was
delivered to these compartments during entry. BTV-1 was
internalised for 15, 30, 60, 90 and 120 minutes before the cells
were fixed and processed for confocal microscopy using PM10
(anti-VP5) to detect internalised virus. Early- and recycling-
endosomes were labelled by incubating the cells with Alexa-568
labelled transferrin during the final 15 minutes of virus uptake (i.e.
for 15 minutes before the cells were fixed). Alternatively, other cells
were double labelled for virus (as above) and LAMP-1 (a marker
for late-endosomes and lysosomes) using Mab 4A1.
Figure 8, shows representative cells from these experiments.
After 15 or 30 minutes of virus uptake, little or no virus co-
localisation with transferrin was observed (Fig. 8A–F). Similarly, at
the other times investigated, virus co-localisation with transferrin
was not observed (data not shown). These results show that during
the first 2 h of entry, BTV-1 does not appear to enter early- or re-
cycling-endosomes, supporting the conclusion that CME is not
required for BTV-1 infection. Similarly, at 15 minutes post-
uptake, virus was not co-localised with LAMP-1 (data not shown).
In contrast, at 0.5 h and 2 h post-entry BTV-1 was observed
Figure 6. Actin disruption inhibits BTV-1 infection. BHK cells
were treated with 2 mM cytochalasin-D and allowed to internalise 568-
Aexa labelled transferrin (shown as red) for 15 minutes (Panel C), or 568-
Alexa labelled dextran (shown as red) (Panel D) or BTV-1 (shown as
green) (Panels B) for 0.5 h. Panel A show virus uptake by mock-treated
cells. The cell nuclei are shown in blue. Scale bar =10 mm. BHK cells
were pre-treated (Pre) with 2 mM cytochalasin-D or 1.5 mM latrunculin-
A, or mock-treated and then infected with BTV-1 (m.o.i.=1). The drugs
were also added to other cells after the start of infection (Post) (see
Methods). At the end of the infection the cells were labelled using
Orab1 (anti-NS2) and scored for infection by confocal microscopy
counting at least 300 cells per condition. The level of infection of the
drug-treated cells was normalised to the level of infection of the mock-
treated cells. The mean 6 SD for triplicate samples of one experiment
representative of two is shown, each giving similar results.
doi:10.1371/journal.pone.0011360.g006
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uptake, ,34% and ,54% of the virus was judged to be co-
localised with LAMP-1. These results are consistent with an
uptake mechanism that delivers BTV-1 to LAMP-1 positive
compartments (late-endosomes/lysosomes) without the need to
first pass through early-endosomes.
Discussion
Infection by Bluetongue virus is acid activated and can be
inhibited by raising endosomal pH. Consistent with these
observations, Forzan et al [45] concluded that BTV-10 infection
of Vero and Hela cells is mediated by CME, with capsid
disassembly and membrane penetration occurring from within
early-endosomes. In this report, we have confirmed that active
endosomal acidification is required for BTV-1 infection of BHK
cells. However, in contrast to previous studies we found that the
clathrin pathway is not the major entry route used by BTV-1 to
infect BHK cells. This conclusion is based on a number of
observations, including; (1) although a low endosomal pH was
shown to be essential for infection, the kinetics of BTV-1 delivery
to acidic compartments was slower than expected for uptake by
the clathrin pathway [53]; (2) during entry, BTV-1 did not co-
localise with transferrin, a commonly used marker for CME; and
(3) cell-entry and infection was not inhibited by expression of three
different DN inhibitors of CME (AP180C, DN-Eps15 and DN-
dynamin-2). Furthermore, both EIPA and cytochalasin-D were
shown to inhibit uptake of BTV-1 but not uptake of transferrin
indicating that BTV-1 and transferrin are internalised by different
endocytic pathways.
Our observations suggest that during entry into BHK cells,
BTV-1 is delivered to acidic compartments via a clathrin
independent route. One possible route is uptake via caveolae as
they can undergo fusion with early-endosomes [17]. However, the
failure of DN-dynamin to inhibit BTV-1 entry and infection of
BHK cells suggests that virus uptake is independent of caveolae.
This conclusion was further supported by showing that BTV-1
infection was not inhibited by cholesterol depletion, which disrupts
several lipid-raft dependent processes including caveolae-mediated
endocytosis. Another clathrin-independent uptake route that leads
to acidic endosomes is the CLIC/GEEC (CLathrin Independent
Carriers/GPI-AP Enriched Endocytic Compartments) pathway
[61,62]. However, in contrast to the entry mechanism used by
BTV-1 to infect BHK cells, the CLIC/GEEC pathway is highly
sensitive to cholesterol depletion [62] and is, therefore, unlikely to
mediate BTV-1 uptake. Recent studies have shown that vesicles
derived from a number of other clathrin-independent pathways
can fuse with early- or late-endosomes [22,24,63,64], and that
viruses can use such mechanisms for infectious entry [15,16,24].
For example, Lymphocytic Choriomeningitis Virus (LCMV) and
Figure 7. BTV-1 is co-localised with dextran during cell-entry. BTV-1 was pre-bound to BHK cells and then internalised in the presence of
Alexa-568 dextran (red) for 0.5 h. The cells were then processed for confocal microscopy using PM10 to detect input virus (green). Panels (A) and (B)
shows dextran uptake for representative cells. Panels (C) and (D) shows virus uptake for the same cells as in panels A and B respectively. Panels (E) and
(F) show merged images for the same cells. Yellow indicates co-localisation. The cell nuclei are shown in blue. Scale bar =10 mm.
doi:10.1371/journal.pone.0011360.g007
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PLoS ONE | www.plosone.org 10 June 2010 | Volume 5 | Issue 6 | e11360Figure 8. During entry BTV-1 is delivered directly to LAMP-1 positive compartments. BTV-1 was pre-bound to BHK cells and
then internalised for 15, 30, or 120 minutes and the cells processed for confocal microscopy using PM10 to detect input virus (green). Panels A–F:
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by clathrin-independent mechanisms that result in virus delivery to
late-endosomes without first passing through early-endosomes
[65,66,67]. However, the uptake pathway used by LCMV appears
distinct from that described here for BTV-1 entry into BHK cells
in several ways including that LCMV uptake and infection are not
blocked by inhibitors of macropinocytosis. The entry route used by
KSHV appears more similar to that described here for BTV-1
since it also shares characteristics of macropinocytosis; however,
unlike the BTV-1 BHK cell entry mechanism, entry of KSHV is
not inhibited by dynasore and is therefore dynamin independent.
On the basis of virus co-localisation with dextran, and the
sensitivity to EIPA or actin disruption, the BTV-1 BHK cell
entry route appears to be most closely related to macropinocy-
tosis [36]. A number of viruses including vaccinia virus
[68,69,70], coxsackievirus B3 [71], HIV [72], KSHV [66],
echovirus 11 [73,74], human rhinovirus-14 [75] and Adenovirus
type 3 [76] have been shown to exploit macropinocytosis, or
macropinocytosis-like endocytic pathways for cell-entry and
infection. Macropinosomes can deliver their contents to late
endosomal compartments (late-endosomes or lysosomes) without
the need for early-endosomes [32,59]. Similarly, the route
described here for BTV-1 entry into BHK cells also appears to
by-pass early-endosomes and delivers virus to late endosomal
compartments. These observations suggest that infection (i.e.
acid induced membrane penetration) might occur from within
late-endosomes or lysosomes. However, we cannot yet be certain
that these compartments are the site of infection as the
intermediate steps of virus trafficking between the plasma
membrane and late-endosomal compartments are not known,
and it is possible that virus could be exposed to a low pH on
transit.
The involvement of dynamin in macropinocytosis is not clear
and studies investigating its role have given conflicting results
[55,58,69,70,77,78]. Similarly, viruses that use macropinocytosis
for infection display different sensitivities to dynamin inhibition
[69,70]. Our studies showed that a DN mutant of the ‘aa’ splice
variant of dynamin-2 does not inhibit BTV-1 uptake or infection
of BHK cells. This DN mutant was shown to inhibit uptake of
transferrin (see Fig. 4) but not dextran (data not shown), indicating
that macropinocytosis/fluid-phase uptake, but not CME is active
in BHK cells expressing this mutant. These observations are
consistent with recent studies by Cao et al., (2007) which show that
different splice variants of dynamin-2 regulate different endocy-
tosis pathways, and that expression of a DN mutant of the ‘aa’
splice variant of dynamin-2 resulted in attenuation of transferrin,
but not dextran uptake [55]. In contrast, BTV-1 uptake was
inhibited by the dynamin inhibitor, dynasore. Since it is likely that
dynasore inhibits all forms of dynamin, this observation suggests
that the mechanism used by BTV-1 to enter BHK cells is dynamin
dependent but relies on a form of dynamin that cannot be
inhibited by DN mutants of the ‘aa’ splice variant of dynamin-2.
In conclusion, we have described here a pathway for BTV-1
uptake and infection of BHK cells that is independent of clathrin
and cholesterol requires dynamin, appears to deliver virus directly
to late-endosomes/lysosomes without first passing through early-
endosomes, and shares characteristics with macropinocytosis.
Recently, Forzan et al., [45] reported that BTV-10 infection of
Vero and Hela cells is mediated by CME with acid-induced
infection occurring within early-endosomes. Hence, BTV joins an
increasing number of viruses that appears able to use more than
one endocytic pathway to initiate infection [21,66,79,80,81,82].
BTV infects a wide variety of cell types in its mammalian hosts
including endothelial cells [37], mononuclear phagocytes [83], cd
T cells [84], dendritic cells [85], and a variety of leukocytes
[37,86]. It is likely that this broad tropism, and the ability of BTV
to replicate in such evolutionary distant hosts results, in part from
an ability to use multiple entry routes to initiate infection.
Moreover, BTV can exist in at least three different forms that are
all considered to be infectious. These include intact virus particles,
infectious sub-viral particles, and virus-cores [46]. These different
particle types have different surface components, and may
therefore also use different entry mechanisms for infection.
However, the entry route used by BTV to infect its natural target
cells and the relevance of these pathways to pathogenesis in the
animal and insect hosts will require further study.
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